TY - JOUR
T1 - Ultrafast photochemistry produces superbright short-wave infrared dots for low-dose in vivo imaging
AU - Santos, Harrisson D. A.
AU - Zabala Gutiérrez, Irene
AU - Shen, Yingli
AU - Lifante, José
AU - Ximendes, Erving
AU - Laurenti, Marco
AU - Méndez-González, Diego
AU - Melle, Sonia
AU - Calderón, Oscar G.
AU - López Cabarcos, Enrique
AU - Fernández, Nuria
AU - Chaves-Coira, Irene
AU - Lucena-Agell, Daniel
AU - Monge, Luis
AU - Mackenzie, Mark D.
AU - Marqués-Hueso, José
AU - Jones, Callum M. S.
AU - Jacinto, Carlos
AU - del Rosal, Blanca
AU - Kar, Ajoy K.
AU - Rubio-Retama, Jorge
AU - Jaque, Daniel
PY - 2020/6/10
Y1 - 2020/6/10
N2 - Optical probes operating in the second near-infrared window (NIR-II, 1,000-1,700 nm), where tissues are highly transparent, have expanded the applicability of fluorescence in the biomedical field. NIR-II fluorescence enables deep-tissue imaging with micrometric resolution in animal models, but is limited by the low brightness of NIR-II probes, which prevents imaging at low excitation intensities and fluorophore concentrations. Here, we present a new generation of probes (Ag2S superdots) derived from chemically synthesized Ag2S dots, on which a protective shell is grown by femtosecond laser irradiation. This shell reduces the structural defects, causing an 80-fold enhancement of the quantum yield. PEGylated Ag2S superdots enable deep-tissue in vivo imaging at low excitation intensities (<10 mW cm-2) and doses (<0.5 mg kg-1), emerging as unrivaled contrast agents for NIR-II preclinical bioimaging. These results establish an approach for developing superbright NIR-II contrast agents based on the synergy between chemical synthesis and ultrafast laser processing.
AB - Optical probes operating in the second near-infrared window (NIR-II, 1,000-1,700 nm), where tissues are highly transparent, have expanded the applicability of fluorescence in the biomedical field. NIR-II fluorescence enables deep-tissue imaging with micrometric resolution in animal models, but is limited by the low brightness of NIR-II probes, which prevents imaging at low excitation intensities and fluorophore concentrations. Here, we present a new generation of probes (Ag2S superdots) derived from chemically synthesized Ag2S dots, on which a protective shell is grown by femtosecond laser irradiation. This shell reduces the structural defects, causing an 80-fold enhancement of the quantum yield. PEGylated Ag2S superdots enable deep-tissue in vivo imaging at low excitation intensities (<10 mW cm-2) and doses (<0.5 mg kg-1), emerging as unrivaled contrast agents for NIR-II preclinical bioimaging. These results establish an approach for developing superbright NIR-II contrast agents based on the synergy between chemical synthesis and ultrafast laser processing.
UR - http://www.scopus.com/inward/record.url?scp=85086331873&partnerID=8YFLogxK
U2 - 10.1038/s41467-020-16333-2
DO - 10.1038/s41467-020-16333-2
M3 - Article
C2 - 32523065
SN - 2041-1723
VL - 11
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 2933
ER -